| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
3 companies
Yale Podnos is Chief Medical Officer at STLN and has filed Form 4s across 3 companies. Yale Podnos's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.5M at current prices.
The biggest single holding is STLN (~$1.8M) as Chief Medical Officer.
Yale Podnos has 21 Form 4 filings on record from November 2021 to July 2026, across 3 companies: Chief Medical Officer at The Oncology Institute (TOIIW), 2026; Chief Medical Officer at Starling Oncology (STLN), 2026; Chief Medical Officer at Oncology Institute (TOI), 2021–2025.
The 40 reported transactions were 12 stock awards, 9 dispositions back to the company, 7 option or other derivative awards and 5 other transactions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $9K and 2 sales worth about $276K.
The only open-market purchase was 9,056 shares of TOI at an average $1.04 on March 26, 2025, about $9K. Twelve months later TOI was up 156%.
The largest open-market sale was 23,452 shares of TOIIW at an average $6.41 on July 14, 2026, about $150K.
Both sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | TOIIW The Oncology Institute, Inc. | Chief Medical Officer | Sale+OE10b5-1 | 23,452 | $6.41 | $150,340.15 | -8.3% | - | - | |
| Jun 8, 2026 | TOIIW The Oncology Institute, Inc. | Chief Medical Officer | Sell10b5-1 | 23,451 | $5.38 | $126,093.68 | -8.3% | - | - | |
| Mar 26, 2025 | TOI Oncology Institute, Inc. | Chief Medical Officer | Buy | 9,056 | $1.04 | $9,433.64 | +12.9% | +94.2% | +156.2% |